Hua Medicine HUMDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.34
- Day Range
- $0.31–0.31
- 52-Week Range
- $0.31–0.50
- Bid/Ask
- $0.28 / $0.35
- Shares Outstanding
- 996.52M
- Market Cap
- $313.26M
- Volume/Avg
- 500 / 7,628
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.61
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin (HMS5552), for the treatment of Type 2 diabetes. Dorzagliatin is a first-in-class glucokinase activator, or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The group majorly operates and generates the majority of its revenue from the PRC.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 328
- Website
- https://www.huamedicine.com
Valuation
|
Metric
|
HUMDF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.14 |
Price/Sales | 4.61 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HUMDF
|
|---|---|
Quick Ratio | 5.57 |
Current Ratio | 6.17 |
Interest Coverage | 135.41 |
Quick Ratio
HUMDF
Profitability
|
Metric
|
HUMDF
|
|---|---|
Return on Assets (Normalized) | −8.20% |
Return on Equity (Normalized) | −35.34% |
Return on Invested Capital (Normalized) | −13.28% |
Return on Assets
HUMDF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|%W>s%KRx | LOCK|D>ysn | $73B | |||
| Haleon PLC ADR
HLN
| LOCK|>j@#$X | LOCK|FLy | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|PCW<^&H | LOCK|S$f$! | $40B | |||
| Zoetis Inc Class A
ZTS
| LOCK|p?!%%%v@ | LOCK|Ck^ | $32B | |||
| Viatris Inc
VTRS
| LOCK|??@?t# | LOCK|^>L | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|!&f | LOCK|wg | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|#L&Qk$ | LOCK|wx | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|@$XNz< | LOCK|&h | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|D?D&vK | LOCK|Spb<! | $3B | |||
| Perrigo Co PLC
PRGO
| LOCK|pqY!&V | LOCK|?sD | $2B |
United States